The Kir2.1 inward-rectifier potassium ion channel is
a target in the treatment of cardiovascular, neurological, renal and
metabolic disorders. Primary assay AID 1672. Validation screens AID
2032 and AID 463252. Counter screens AID 2105, AID 2345, AID 2236, and
AID 2329. The final set of 172 active compounds was constructed
subtracting the actives in AID 2105, AID 2345, AID 2236, and AID 2329
from the molecules found active in both, AID… See the full description on the dataset page: https://huggingface.co/datasets/jablonkagroup/potassium_ion_channel_kir2_1_butkiewicz.
